BCKDK anticorps (N-Term)
Aperçu rapide pour BCKDK anticorps (N-Term) (ABIN632248)
Antigène
Voir toutes BCKDK AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- BCKDK antibody was raised against the N terminal of BCKDK
-
Purification
- Affinity purified
-
Immunogène
- BCKDK antibody was raised using the N terminal of BCKDK corresponding to a region with amino acids CLPFIIGCNPTILHVHELYIRAFQKLTDFPPIKDQADEAQYCQLVRQLLD
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BCKDK Blocking Peptide, (ABIN937128), is also available for use as a blocking control in assays to test for specificity of this BCKDK antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BCKDK antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase (BCKDK))
-
Autre désignation
- BCKDK
-
Sujet
- BCkDaK belongs to the PDK/BCkDaK protein kinase family. It contains 1 histidine kinase domain. BCkDaK catalyzes the phosphorylation and inactivation of the branched-chain alpha-ketoacid dehydrogenase complex, the key regulatory enzyme of the valine, leucine and isoleucine catabolic pathways. BCkDaK is the key enzyme that regulates the activity state of the BCkDa complex.
-
Poids moléculaire
- 43 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-